abstract |
FIELD: chemistry. n SUBSTANCE: invention relates to use of a sigma ligand, which is a 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine or a pharmaceutically acceptable salt thereof. n EFFECT: prevention and/or treatment of pain associated with type 2 diabetes and related symptoms. n 6 cl, 9 dwg, 4 ex |